ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

MNOV Medicinova Inc

1.38
0.00 (0.00%)
Pre Mercado
Última actualización: 07:00:56
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Medicinova Inc MNOV NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 1.38 07:00:56
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.38
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/4/202418:00GLOBEMediciNova Announces Abstract Regarding Results of a..
26/3/202418:00GLOBEMediciNova Receives a Notice of Allowance for a New Patent..
20/3/202418:00GLOBEMediciNova Announces Two Abstracts regarding MN-001..
12/3/202405:30GLOBEMediciNova Announces New Data and Results of MN-166..
15/2/202415:25EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
19/1/202415:27EDGAR2Form S-8 POS - Securities to be offered to employees in..
19/1/202415:25EDGAR2Form S-8 POS - Securities to be offered to employees in..
19/1/202415:23EDGAR2Form S-8 POS - Securities to be offered to employees in..
19/1/202415:21EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/1/202405:00GLOBEMediciNova Receives a Notice of Grant for a New Patent..
11/1/202415:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202415:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202415:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202317:00GLOBEMediciNova Announces Abstract Regarding MN-166 (ibudilast)..
06/12/202317:00GLOBEMediciNova Receives a Notice of Decision to Grant for a New..
20/11/202306:42IHMARKETNEWSStocks Set to Open Higher as Investors Await FOMC Minutes..
19/11/202317:00GLOBEMediciNova Announces New Data and Results of a Phase 2..
09/11/202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/10/202300:00GLOBEMediciNova’s Collaborator Initiates Clinical Development of..
10/10/202318:00GLOBEMediciNova Receives a Notice of Allowance for a New Patent..
04/10/202318:00GLOBEMediciNova Receives Gene Therapy Milestone Payment
27/9/202318:00GLOBEMediciNova Announces Results of Studies under BARDA Contract..
17/8/202318:00GLOBEMediciNova Announces Abstract Regarding MN-166 (ibudilast)..
16/8/202318:00GLOBEMediciNova Receives a Notice of Intention to Grant for a New..
15/8/202318:00GLOBEMediciNova Receives a New Patent Covering MN-001 for the..
14/8/202318:00GLOBEMediciNova Receives a Notice of Intention to Grant for a New..
09/8/202315:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202315:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202315:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/8/202315:05EDGAR2Form 8-K - Current report
29/6/202305:00GLOBEMediciNova Announces Presentation of Results from the Phase..
14/5/202318:00GLOBEMediciNova Receives a Notice of Intention to Grant for a New..

Su Consulta Reciente

Delayed Upgrade Clock